vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and XPLR Infrastructure, LP (XIFR). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $249.0M, roughly 1.1× XPLR Infrastructure, LP). XPLR Infrastructure, LP runs the higher net margin — 11.2% vs 0.7%, a 10.5% gap on every dollar of revenue. On growth, XPLR Infrastructure, LP posted the faster year-over-year revenue change (-15.3% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-88.0M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

XPLR Infrastructure is a publicly traded subsidiary of NextEra Energy, is a Juno Beach, Florida-based renewable energy company.

HCM vs XIFR — Head-to-Head

Bigger by revenue
HCM
HCM
1.1× larger
HCM
$270.8M
$249.0M
XIFR
Growing faster (revenue YoY)
XIFR
XIFR
+1.2% gap
XIFR
-15.3%
-16.5%
HCM
Higher net margin
XIFR
XIFR
10.5% more per $
XIFR
11.2%
0.7%
HCM
More free cash flow
HCM
HCM
$91.4M more FCF
HCM
$3.4M
$-88.0M
XIFR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
XIFR
XIFR
Revenue
$270.8M
$249.0M
Net Profit
$2.0M
$28.0M
Gross Margin
37.7%
Operating Margin
-13.2%
-19.3%
Net Margin
0.7%
11.2%
Revenue YoY
-16.5%
-15.3%
Net Profit YoY
-83.6%
124.3%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
XIFR
XIFR
Q4 25
$270.8M
$249.0M
Q3 25
$315.0M
Q2 25
$277.7M
$342.0M
Q1 25
$324.5M
$282.0M
Q4 24
$294.0M
Q3 24
$319.0M
Q2 24
$305.7M
$360.0M
Q1 24
$257.0M
Net Profit
HCM
HCM
XIFR
XIFR
Q4 25
$2.0M
$28.0M
Q3 25
$-37.0M
Q2 25
$455.0M
$79.0M
Q1 25
$11.9M
$-98.0M
Q4 24
$-115.0M
Q3 24
$-40.0M
Q2 24
$25.8M
$62.0M
Q1 24
$70.0M
Gross Margin
HCM
HCM
XIFR
XIFR
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
XIFR
XIFR
Q4 25
-13.2%
-19.3%
Q3 25
1.6%
Q2 25
-1.3%
26.3%
Q1 25
-5.0%
-82.6%
Q4 24
-188.1%
Q3 24
15.4%
Q2 24
-9.0%
18.3%
Q1 24
-8.2%
Net Margin
HCM
HCM
XIFR
XIFR
Q4 25
0.7%
11.2%
Q3 25
-11.7%
Q2 25
163.8%
23.1%
Q1 25
3.7%
-34.8%
Q4 24
-39.1%
Q3 24
-12.5%
Q2 24
8.4%
17.2%
Q1 24
27.2%
EPS (diluted)
HCM
HCM
XIFR
XIFR
Q4 25
$0.00
Q3 25
$-0.40
Q2 25
$0.52
$0.84
Q1 25
$0.01
$-1.05
Q4 24
Q3 24
$-0.43
Q2 24
$0.03
$0.66
Q1 24
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
XIFR
XIFR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$960.0M
Total DebtLower is stronger
$93.2M
$6.2B
Stockholders' EquityBook value
$1.2B
$10.9B
Total Assets
$1.8B
$19.6B
Debt / EquityLower = less leverage
0.08×
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
XIFR
XIFR
Q4 25
$1.4B
$960.0M
Q3 25
$711.0M
Q2 25
$1.4B
$880.0M
Q1 25
$836.1M
$1.5B
Q4 24
$283.0M
Q3 24
$290.0M
Q2 24
$802.5M
$281.0M
Q1 24
$245.0M
Total Debt
HCM
HCM
XIFR
XIFR
Q4 25
$93.2M
$6.2B
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
$5.3B
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
XIFR
XIFR
Q4 25
$1.2B
$10.9B
Q3 25
$11.0B
Q2 25
$1.2B
$11.3B
Q1 25
$759.9M
$12.6B
Q4 24
$12.9B
Q3 24
$13.6B
Q2 24
$740.1M
$13.9B
Q1 24
$14.0B
Total Assets
HCM
HCM
XIFR
XIFR
Q4 25
$1.8B
$19.6B
Q3 25
$19.1B
Q2 25
$1.8B
$20.5B
Q1 25
$1.3B
$21.4B
Q4 24
$20.3B
Q3 24
$20.9B
Q2 24
$1.3B
$21.7B
Q1 24
$22.3B
Debt / Equity
HCM
HCM
XIFR
XIFR
Q4 25
0.08×
0.57×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
0.41×
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
XIFR
XIFR
Operating Cash FlowLast quarter
$8.2M
$186.0M
Free Cash FlowOCF − Capex
$3.4M
$-88.0M
FCF MarginFCF / Revenue
1.2%
-35.3%
Capex IntensityCapex / Revenue
1.8%
110.0%
Cash ConversionOCF / Net Profit
4.21×
6.64×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-219.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
XIFR
XIFR
Q4 25
$8.2M
$186.0M
Q3 25
$231.0M
Q2 25
$-72.9M
$232.0M
Q1 25
$40.3M
$90.0M
Q4 24
$283.0M
Q3 24
$208.0M
Q2 24
$-39.8M
$231.0M
Q1 24
$78.0M
Free Cash Flow
HCM
HCM
XIFR
XIFR
Q4 25
$3.4M
$-88.0M
Q3 25
$-283.0M
Q2 25
$-82.2M
$151.0M
Q1 25
$32.5M
$1.0M
Q4 24
$231.0M
Q3 24
$152.0M
Q2 24
$-49.9M
$162.0M
Q1 24
$14.0M
FCF Margin
HCM
HCM
XIFR
XIFR
Q4 25
1.2%
-35.3%
Q3 25
-89.8%
Q2 25
-29.6%
44.2%
Q1 25
10.0%
0.4%
Q4 24
78.6%
Q3 24
47.6%
Q2 24
-16.3%
45.0%
Q1 24
5.4%
Capex Intensity
HCM
HCM
XIFR
XIFR
Q4 25
1.8%
110.0%
Q3 25
163.2%
Q2 25
3.3%
23.7%
Q1 25
2.4%
31.6%
Q4 24
17.7%
Q3 24
17.6%
Q2 24
3.3%
19.2%
Q1 24
24.9%
Cash Conversion
HCM
HCM
XIFR
XIFR
Q4 25
4.21×
6.64×
Q3 25
Q2 25
-0.16×
2.94×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
-1.54×
3.73×
Q1 24
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

XIFR
XIFR

Renewable Energy Sales$238.0M96%
Related Party$8.0M3%

Related Comparisons